Rheumatology
News
Trial backs rituximab for maintenance of ANCA-associated vasculitis remission
Key clinical point: Rituximab maintenance therapy is superior to standard azathioprine maintenance for ANCA-associated vasculitis. Major finding:...
News
Eastern United States has the highest arthritis rates
News
Disease activity, not lipid levels, appear to affect CV risk with tocilizumab
Key clinical point: Disease activity, rather than lipid levels, is an independent predictor of cardiovascular event risk during treatment with...
News
Brain changes identified in chronic fatigue syndrome
Key clinical point: Increased fractional anisotropy in the anterior right arcuate fasciculus may eventually serve as a biomarker for CFS if larger...
News
ACR 2010 criteria for fibromyalgia critiqued
Key clinical point: Both ACR 2010 and modified ACR 2010 criteria for diagnosing fibromyalgia have “unsatisfactory” sensitivity and specificity....
Conference Coverage
In psoriasis, is pushing for PASI 90 really worthwhile?
Key clinical point: Psoriasis patients who obtain a PASI 90 response report the quality of life burden imposed by the disease is lifted a full...
News
FDA approves new abuse-prevention labeling for extended-release Embeda
News
Tocilizumab and tofacitinib increase lipids in RA patients
Key clinical point: The biologic tocilizumab and the JAK inhibitor increase lipid levels in RA patients.
News
Hand exercise program worthwhile, cost effective in RA patients
Key clinical point: A tailored hand exercise program for RA patients is a cost-effective intervention for restoring hand function. Major finding:...
News
Biomarkers identify RA patients at risk of lung disease
Key clinical point: The discovery of blood biomarkers may lead to early identification of lung complications in RA patients. Major finding: MMP-7...
News
RA patients’ readmission rates after joint replacement are rising
Key clinical point: The 90-day risk of readmission after hip or knee replacement surgery is higher in patients with RA, compared with patients...